SAN DIEGO, Aug. 21, 2013 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to announce to shareholders and the general public that The Depository Trust Company (DTC) has determined, effective immediately, to lift the deposit transaction restriction (“chill”) and has resumed accepting deposits.
Michelle Sides, Chief Operating Officer and Chairman of the Board of Directors of Medical Marijuana Inc., stated, “This has been a much longer and more strenuous process than we had anticipated; however, due to our legal team’s incredible persistence, we are proud to announce that the ‘chill’ has finally been lifted. I would like to thank our team and our shareholders for their continued support.”
A copy of the DTC “chill” lift letter can be found at OTCMarkets.com.
According to the U.S. government, every product derived from cannabis is categorized as marijuana—including hemp. We, therefore, use the word “marijuana” as an all-encompassing term to cover cannabis, medical marijuana, marijuana and hemp. We believe that “cannabis” should be the standard term used for all medical products; as the industry matures, we will be phasing out the words “medical marijuana” and “marijuana” from the company’s vocabulary.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com/
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products and is involved with federally legal distribution of medical marijuana-based products within certain international markets. We use the following names for informational purposes only, all of which refer to the legal industrial hemp plant: cannabis, canipa, kanipa, kanna, canna, kanabis, marijuana, medical marijuana, hemp, and industrial hemp.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
Investor relations contact:
Stuart T. Smith